[ESPR] YoY Quarter Result on 30-Jun-2015 [#Q2]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
06-Aug-2015
Financial Year
2015
Quarter
30-Jun-2015 [#Q2]
Profit Trend
QoQ- -8.10%
YoY- -34.17%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -45,730 -43,337 -14,035 -12,395 -9,238 -6,921 -3,166 56.02%
Tax 0 433 494 337 18 112 304 -
NP -45,730 -43,337 -14,035 -12,395 -9,238 -6,921 -3,166 56.02%
Tax Rate - - - - - - - -
Total Cost 45,730 43,337 14,035 12,395 9,238 6,921 3,166 56.02%
Ratio Analysis
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
EPS -1.71 -1.92 -0.62 -0.55 -0.60 -0.47 -0.33 31.53%
EPS Diluted -1.71 -1.92 -0.62 -0.55 -0.60 -0.47 -0.33 31.53%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.